Longevity Med Summit for the first time in Portugal

The Longevity Med Summit "will make it possible to create greater attractiveness for Portugal by sharing...

Carlos Monteiro talks to País Económico about the importance of Biojam for the Iberian Peninsula

After a successful career in various pharmaceutical multinationals in France, Germany and the...

Biojam Inovar Award 2022

It was as part of the XXIX Annual Meeting of the Paediatric Haematology and Oncology Society that...

Partnership between Biojam Holding Group and PCL South Korea

The South Korean press has revealed a partnership between Biojam Holding Group and PCL...

"Innovation in Health with Portuguese DNA" - Carlos Monteiro in conversation with Exame

Founded by Carlos Jorge Monteiro in 2006, the pharmaceutical company that leads the Iberian Peninsula's...

Our Direction is Always Innovation

Carlos Monteiro, Founder & CEO Biojam Holding Group, in an interview with Portugal em Destaque, emphasised...

IV Multidisciplinary Conference on General and Family Medicine

Biojam bets on the FGM segment Biojam bets on the General Medicine and...

Biojam prepared to ensure Covid-19 testing during sixth wave

Following the creation of a logistics hub for the supply of COVID-19 tests for the...

Mais Saúde - Carlos Monteiro in conversation with Expresso

Founded by Carlos Monteiro, Biojam stands out in the Iberian Peninsula in the field of paediatric oncology....

BIOJAM leader warns of a sixth wave and emphasises the importance of testing

With the number of Covid-19 cases on the rise, BIOJAM CEO warns of...